Abstract

BackgroundSunitinib (SU) is an oral, small-molecule, multi-targeted tyrosine kinase receptor inhibitor that is approved for the treatment of renal cell carcinoma (RCC). However, several patients either do not respond to...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma
T Powles ... G De Velasco
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 32
T Powles, et. al.T Powles ... G De Velasco
28 Sep 2021
Axitinib: Oral tyrosine kinase inhibitor for renal cell carcinoma
Maria G Tanzi
Pharmacy Today | VOL. 18
Maria G TanziMaria G Tanzi
01 Mar 2012
Glutathione peroxidase family and survival prognosis in patients with renal cell carcinoma.
Juan Li ... Qiling Liu
Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences | VOL. 47
Juan Li, et. al.Juan Li ... Qiling Liu
28 May 2022
637 Immune-related adverse events (irAEs) may indicate a favorable prognosis in metastatic renal cell carcinoma (mRCC) patients treated with immune checkpoint inhibitors (ICI)
Dylan Martini ... Bassel Nazha
-
Dylan Martini, et. al.Dylan Martini ... Bassel Nazha
01 Nov 2020
View more papers

More From: European Journal of Hospital Pharmacy: Science and Practice

Paper Title
Journal
Date
Author
Patient reported medication-related problems, adherence and waste of oral anticancer medication over time
Patricia M L A Van Den Bemt ... Liset Van Dijk
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Patricia M L A Van Den Bemt, et. al.Patricia M L A Van Den Bemt ... Liset Van Dijk
17 Jul 2024
Pharmacotherapy of carbamazepine-treated patient after bariatric surgery: a complex interplay between altered absorption and drug–drug interactions
Alena Pilková ... Martin Matoulek
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Alena Pilková, et. al.Alena Pilková ... Martin Matoulek
17 Jul 2024
Risk assessment of clinical trial protocols: a tool for hospital pharmacists to reduce human error in experimental drug management
Giulia Cancellieri ... Piera Polidori
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Giulia Cancellieri, et. al.Giulia Cancellieri ... Piera Polidori
15 Jul 2024
How can oral second-line anti-tuberculosis medications be administered to an extremely preterm neonate?
Tien Thuy Ngo ... Charis Lau
European Journal of Hospital Pharmacy: Science and Practice | VOL. -
Tien Thuy Ngo, et. al.Tien Thuy Ngo ... Charis Lau
13 Jul 2024
View more papers